Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study

Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer’s disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has previously been explored in MCI and AD, but it has yet...

Full description

Bibliographic Details
Main Authors:	Pernille L. Kjeldsen, Peter Parbo, Kim V. Hansen, Joel F.A. Aanerud, Rola Ismail, Peter H. Nissen, Rikke B. Dalby, Malene F. Damholdt, Per Borghammer, David J. Brooks
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Aging Brain
Subjects:	Preclinical Alzheimer’s disease Positron emission tomography Amyloid deposition Asymmetry
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589958922000202

Similar Items

Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort
by: Christina B. Young, et al.
Published: (2023-01-01)

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
by: Ashvini Keshavan, et al.
Published: (2021-01-01)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
by: Benjamin M. Doherty, et al.
Published: (2015-06-01)

Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
by: Joseph Therriault, et al.
Published: (2023-07-01)

Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism
by: Thomas E. H. Justesen, et al.
Published: (2023-05-01)

Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01)

Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy
by: Anika Finze, et al.
Published: (2022-02-01)

Probabilistic estimation for across‐batch compatibility enhancement for amyloid PET
by: Murat Bilgel
Published: (2023-07-01)

Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review
by: Jhih-Yong Yang, et al.
Published: (2023-04-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
by: Eline A. J. Willemse, et al.
Published: (2021-01-01)

Fractal motor activity regulation and sex differences in preclinical Alzheimer's disease pathology
by: Lei Gao, et al.
Published: (2021-01-01)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
by: Keun You Kim, et al.
Published: (2022-11-01)

Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial
by: Jennifer Ngolab, et al.
Published: (2021-01-01)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
by: Lyduine E. Collij, et al.
Published: (2021-01-01)

White matter microstructure disruption in early stage amyloid pathology
by: Lyduine E. Collij, et al.
Published: (2021-01-01)

Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
by: Lorenzini Luigi, et al.
Published: (2022-01-01)

Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
by: Ilse Bader, et al.
Published: (2023-11-01)

Image quality evaluation for two different positron emitters in a preclinical PET scanner
by: Rodrigo Modesto Gadelha, et al.
Published: (2020-09-01)

Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology
by: Adam Martersteck, et al.
Published: (2022-08-01)

Compensating Positron Range Effects of Ga-68 in Preclinical PET Imaging by Using Convolutional Neural Network: A Monte Carlo Simulation Study
by: Ching-Ching Yang
Published: (2021-12-01)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
by: Min Young Chun, et al.
Published: (2023-03-01)

The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact
by: Lyduine E. Collij, et al.
Published: (2023-01-01)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
by: Min Seok Baek, et al.
Published: (2020-10-01)

Case Report: Taxifolin for neurosurgery-associated early-onset cerebral amyloid angiopathy
by: Maxwell C. Y. Choi, et al.
Published: (2024-03-01)

5th Internatinal TPCF Preclinical Imaging Symposium
by: 5th Internatinal TPCF Preclinical Imaging
Published: (2023-08-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-12-01)

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
by: Taewon Kim, et al.
Published: (2022-12-01)

Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status
by: Shogyoku Bun, et al.
Published: (2023-09-01)

Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals
by: Sung Hoon Kang, et al.
Published: (2023-10-01)

Accurate Transmission-Less Attenuation Correction Method for Amyloid-β Brain PET Using Deep Neural Network
by: Bo-Hye Choi, et al.
Published: (2021-07-01)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
by: Timo Pekkala, et al.
Published: (2020-07-01)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
by: Michelle R. Campbell, et al.
Published: (2021-01-01)

Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by <sup>18</sup>F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Geon Ha Kim, et al.
Published: (2024-03-01)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
by: Jori Tomassen, et al.
Published: (2022-12-01)

Sensory impairment and beta‐amyloid deposition in the Baltimore longitudinal study of aging
by: Lekha Yesantharao, et al.
Published: (2023-04-01)

Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
by: Shenqing Zhang, et al.
Published: (2023-07-01)

Amyloid proteins : methods and protocols /
by: Sigurdsson, Einar M.
Published: (2005)

The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
by: Jiaying Lu, et al.
Published: (2023-01-01)

Application of a multimedia-supported manikin system for preclinical dental training
by: Yi Yang, et al.
Published: (2022-09-01)